Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency
The DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index.
Abstract
Although the use of the insulin tolerance test (ITT) for the diagnosis of adult GH deficiency is well established, diagnostic peak GH cut-points for other commonly used GH stimulation tests are less clearly established. Despite that fact, the majority of patients in the United States who are evaluated for GH deficiency do not undergo insulin tolerance testing. The aim of this study was to evaluate the relative utility of six different methods of testing for adult GH deficiency currently used in practice in the United States and to develop diagnostic cut-points for each of these tests. Thirty-nine patients (26 male, 13 female) with adult-onset hypothalamic-pituitary disease and multiple pituitary hormone deficiencies were studied in comparison with age-, sex-, estrogen status-, and body mass index-matched control subjects (n = 34; 20 male, 14 female). A third group of patients (n = 21) with adult-onset hypothalamic-pituitary disease and no more than one additional pituitary hormone deficiency was also studied. The primary end-point was peak serum GH response to five GH stimulation tests administered in random order at five separate visits: ITT, arginine (ARG), levodopa (L-DOPA), ARG plus L-DOPA, and ARG plus GHRH. Serum IGF-I concentrations were also measured on two occasions. For purposes of analysis, patients with multiple pituitary hormone deficiencies were assumed to be GH deficient. Three diagnostic cut-points were calculated for each test to provide optimal separation of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While interpreting GH values, one should also consider multiple factors, including nutritional and hormonal status, exercise, body weight, and age, all of which may influence pituitary GH secretion (85,86).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [86]
Citations
Cites
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
IRANMANESH, A., LIZARRALDE, G., & VELDHUIS, J. D. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1081 · Cited by 672 · cited 1×
“Each one unit increase in BMI has been shown to be associated with a 6% decrease in 24-h GH secretion (35).”
Background; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
VELDHUIS, J. D., IRANMANESH, A., HO, K. K. Y., WATERS, M. J., JOHNSON, M. L., & LIZARRALDE, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-51 · Cited by 480 · cited 1×
“Obesity suppresses GH release, with 24-h GH levels in obese men reduced by 75% in comparison with age-matched normal weight subjects (34).”
The Diagnosis of Growth Hormone Deficiency in Adults
Ho, K. K. Y., & Hoffman, D. M. (1997) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.6.suppl10_35 · Cited by 428
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Shalet, S. M., Toogood, A., Rahim, A., & Brennan, B. M. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0329 · Cited by 414 · cited 4×
“Therefore, evaluation of tests designed to diagnose GHD should control for such variables (18, 19).”
BackgroundInfluentialDiagnosis of growth-hormone deficiency in adults
Hoffman, D. M., O'Sullivan, A. J., Ho, K. K. Y., & Baxter, R. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90181-3 · Cited by 386
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
COPELAND, K. C., UNDERWOOD, L. E., & VAN WYK, J. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-690 · Cited by 352 · cited 1×
“GH therapy was not administered for at least one month before study entry, based on data that demonstrate that serum IGF-I levels return to nearbaseline within 48 h after cessation of GH (22).”
MethodArginine Stimulates Growth Hormone Secretion by Suppressing Endogenous Somatostatin Secretion*
ALBA-ROTH, J., MÜLLER, O. A., SCHOPOHL, J., & WERDER, K. V. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1186 · Cited by 337 · cited 1×
“This amino acid is believed to increase GH by suppressing endogenous somatostatin (11, 45, 46).”
Background
Research works printed but not linked: 2
- 1998, AACE clinical practice guidelines for growth hormone use in adults and children., Endocr Pract, 4, 165
- Mausner, 1974, Epidemiology, Philadelphia: W. B. Saunders;, 237
Cited by
Items 201–300 of 422
Concepts in the Diagnosis of Adult Growth Hormone Deficiency
Biller, B. M. K. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110478 · Cited by 15
“The ITT is an excellent diagnostic test, but it has some drawbacks. Its use may be associated with significant side effects, it is more labor-intensive than some other tests and there are contraindications that may prohibit its use (e.g., in patients with a history of seizures, psychiatric illness, cardiovascular or c…”
MethodSelf-citationSesmilo, G., Halperin, I., & Puig-Domingo, M. (2007) · HORMONES · doi:10.14310/horm.2002.1111013 · Cited by 14
“To rule out GHD, provocative testing is necessary.(23) Universal provocative testing in all patients with moderate-to-severe TBI is both troublesome and expensive for the patient.”
BackgroundKLAUS, B. M., Sachse, R., Ammer, N., Kelepouris, N., & Ostrow, V. (2020) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2020.101321 · Cited by 14
Bonert, V. S., & Melmed, S. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00004-0 · Cited by 23
Self-citationNatural History of Growth Hormone Deficiency in a Pediatric Cohort
Deillon, E., Hauschild, M., Faouzi, M., Stoppa‐Vaucher, S., Elowe-Gruau, É., Dwyer, A. A., Theintz, G. E., Dubuis, J.-M., Mullis, P. E., Pitteloud, N., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369392 · Cited by 15
The management of adult growth hormone deficiency syndrome
Laursen, T., Jørgensen, J. O. L., & Christiansen, J. S. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.14.2435 · Cited by 14
GH Use in the Transition of Adolescence to Adulthood
Mauras, N. (2010) · Endocrine development · doi:10.1159/000316131 · Cited by 18
Growth hormone treatment in adults with growth hormone deficiency: The transition
Molitch, M. E. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347046 · Cited by 14
Growth hormone status predicts left ventricular mass in patients after cure of acromegaly
Wexler, T., Durst, R. Y., McCarty, D., Picard, M. H., Gunnell, L., Omer, Z. B., Fazeli, P. K., Miller, K. K., & Klibanski, A. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.05.003 · Cited by 14
“Study participants were diagnosed with GHD based on a peak GH<5 ng/ml in response to GHRH–arginine stimulation, performed as previously described [39], or an IGF-1 level more than two standard deviations below the age-specific normal range in subjects with at least three other documented anterior pituitary hormone def…”
Testing for growth hormone deficiency in adults
Kargi, A. Y., & Merriam, G. R. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835430da · Cited by 14
“Absent GHRH, combining arginine with l-DOPA significantly improves the performance of the test, but its performance is still inferior to ITT or GST [25].”
BackgroundInfluentialSevere growth hormone deficiency is rare in surgically-cured acromegalics
Fujio, S., Tokimura, H., Hirano, H., Hanaya, R., Kubo, F., Yunoue, S., Bohara, M., Kinoshita, Y., Tominaga, A., Arimura, H., et al. (2012) · Pituitary · doi:10.1007/s11102-012-0424-6 · Cited by 15
Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity
Stanley, T. L., Feldpausch, M. N., Murphy, C. A., Grinspoon, S. K., & Makimura, H. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.11.001 · Cited by 13
“as the value least likely to result in misclassification of GH deficiency with the GHRH–arginine stimulation in comparison with the gold standard, insulin tolerance test among a primarily obese subject cohort [20].”
Transition to the adult endocrine clinic: testing pituitary function – what tests and when?
Geffner, M. E. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00067-4 · Cited by 16
“Results with GHRH/arginine are comparable to those using insulin, and these agents are preferred by patients [16].”
Kinoshita, Y., Tominaga, A., Usui, S., Arita, K., Sakoguchi, T., Sugiyama, K., & Kurisu, K. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0230 · Cited by 13
Carmichael, J. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00010-6 · Cited by 14
Biomarkers of GH action in children and adults
Schilbach, K., Olsson, D. S., Boguszewski, M. C. D. S., Bidlingmaier, M., Johannsson, G., & Jørgensen, J.-O. L. (2018) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2018.03.005 · Cited by 16
Rational use of the laboratory for childhood and adult growth hormone deficiency
Pandian, R., & Nakamoto, J. M. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.01.009 · Cited by 14
“For diagnosis of adult GHD, the study by Biller et al [37] demonstrated that a GH cutoff of 5.”
BackgroundMethodZayed, A. A., Ali, M. K. M., Al‐Ani, M. A., Momani, M. S., & Yousef, A. (2014) · Clinical Endocrinology · doi:10.1111/cen.12510 · Cited by 12
Evaluation of growth hormone stimulation tests in cured acromegalic patients
Conceição, F. L., Fisker, S., Andersen, M., Kaal, A., Jørgensen, J. O. L., Vaisman, M., & Christiansen, J. S. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00124-2 · Cited by 14
Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review
Martin, B. S. D. S., Ferreira, V. G., Bitencourt, M. R., Pereira, P. C. G., Carrilho, E., Assunção, N. A., & Carvalho, L. R. S. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000300 · Cited by 20
“It is documented that adult patients with adquired GHD can have normal IGF1 for age and once under stimulous test, the response can be absent confirming GHD (21-24).”
BackgroundCardiovascular risk in aging and obesity: Is there a role for GH?
Gola, M., Bonadonna, S., Doga, M., Mazziotti, G., & Giustina, A. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347561 · Cited by 15
Evaluation of pituitary function in the fatigued patient: a review of 59 cases
Greenfield, J. R., & Samaras, K. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02010 · Cited by 12
Salvatore, E., Rinaldi, C., Tucci, T., Maio, L. D., Somma, C. D., Savastano, S., Lombardi, G., Filla, A., Colao, A. M. L., & Michele, G. D. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.208553 · Cited by 12
“4 ng/ml at T60 or T90 time points was considered abnormal, as for guidelines for adult GH deficiency (GHD) diagnosis.(17) Basal IGF-1 was also measured, using a chemoluminescent IGF-1 assay (Immunolite 2000, Medical System, Genoa, Italy) with the limit of detection of 20 mg/l.”
MethodWhat Endocrinologists Should Know About Growth Hormone Measurements
Bidlingmaier, M., & Strasburger, C. J. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.11.004 · Cited by 12
Stepping into Adulthood: The Transition Period
Shalet, S. M. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080904 · Cited by 12
“However, the arginine growth hormone-releasing hormone (ARG GHRH) test has also shown a diagnostic accuracy close to the ITT [”
BackgroundApproach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder
Makras, P., Erickson, D. Z., Davidge-Pitts, C. J., Diamond, E. L., Allen, C. E., McClain, K. L., Abeykoon, J. P., Go, R. S., Siwakoti, K., Sotoudeh, H., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae827 · Cited by 12
Gu, J., Wu, Q., Zhang, Q., You, Q., & Wang, L. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114742 · Cited by 12
Dynamic Tests in Pituitary Endocrinology: Pitfalls in Interpretation during Aging
Caputo, M., Mele, C., Ferrero, A., Leone, I., Daffara, T., Marzullo, P., Prodam, F., & Aimaretti, G. (2021) · Neuroendocrinology · doi:10.1159/000514434 · Cited by 12
Colao, A., Pivonello, R., Auriemma, R. S., Grasso, L. F. S., Galdiero, M., Pivonello, C., Lombardi, G., & Savastano, S. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03896.x · Cited by 11
L -Dopa Stimulates Cortisol Secretion through Adrenocorticotropic Hormone Release in Short Children
Marakaki, C., Papadimitriou, D. T., Kleanthous, K., Papadopoulou, A., & Papadimitriou, A. (2015) · Hormone Research in Paediatrics · doi:10.1159/000439532 · Cited by 11
Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency.
Eskes, S. A., Tomasoa, N. B., Endert, E., Geskus, R. B., Fliers, E., & Wiersinga, W. M. (2009) · PubMed · Cited by 14
Evaluation of pituitary function
Cheer, K., & Trainer, P. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00010-1 · Cited by 12
Evaluation of the reproducibility of the GHRH plus GHRP‐6 test of growth hormone reserve in adults
POPOVIC, V. M., Pekić, S., Micić, D., Damjanovic, S. S., Marikovic, J., Simic, M., Diéguez, C., & Casanueva, F. F. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01955.x · Cited by 11
Rigamonti, A. E., Grugni, G., Marazzi, N., Bini, S., Bidlingmaier, M., & Sartório, A. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.06.002 · Cited by 10
Shea, H. C., & Levy, R. A. (2011) · Endocrine Practice · doi:10.4158/ep11168.ra · Cited by 11
Tzanela, M., Zianni, D., Bilariki, K., Vezalis, A., Gavalas, N. G., Szabo, A., Drimala, P., Vassiliadi, D. A., & Vassilopoulos, C. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0390 · Cited by 12
Hypopituitarism 3 and 12 months after traumatic brain injury and subarachnoid haemorrhage
Jonasdottir, A. D., Sigurjonsson, P., Olafsson, I. H., Karason, S., Sigthorsson, G., & Sigurjonsdottir, H. A. (2018) · Brain Injury · doi:10.1080/02699052.2017.1418906 · Cited by 9
“However, GHRH-Arginine has been shown to be a validated alternative when the ITT is contraindicated (22,37).”
BackgroundAnterior pituitary function in Rathke’s cleft cysts versus nonfunctioning pituitary adenomas
Fujii, M., Nakagawa, A., Tachibana, O., Iizuka, H., & Koya, D. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0050 · Cited by 9
“However, considering the arginine + GHRH test is accepted as an alternative to the IIH test for diag‐ nosing GH deficiency [21, 28], the GH responses evoked by GHRH could be diminished even in cases with supra‐ hypophysial damage.”
BackgroundImpaired IGF1-GH axis and new therapeutic options in Alström Syndrome patients: a case series
Mihai, C. M., Catrinoiu, D., Toringhibel, M., Stoicescu, R. M., Negreanu–Pîrjol, T., & Hâncu, A. (2009) · Cases Journal · doi:10.1186/1757-1626-2-19 · Cited by 11
“Demonstrating GHD in an Alström syndrome patient, Tai TS, Lin SY, Sheu WH assessed the metabolic effects of growth hormone therapy concluding that Re-GH therapy might have beneficial effects on body composition, liver fat content, lipid profiles, and insulin resistance in Alström syndrome patients, with improvement of…”
BackgroundInfluentialIGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction
Tirosh, A., Toledano, Y., Masri‐Iraqi, H., Eizenberg, Y., Tzvetov, G., Hirsch, D., Benbassat, C. A., Robenshtok, E., & Shimon, I. (2016) · Pituitary · doi:10.1007/s11102-016-0718-1 · Cited by 9
“(12), and a 100 % PPV of IGF-I SDS\-2 for the diagnosis of adult-onset GH deficiency, albeit with very low sensitivity (46 %) [3].”
BackgroundInfluentialDrummond, J., Soares, B. S., Vieira, É. L. M., Pedrosa, W., Teixeira, A. L., & Ribeiro‐Oliveira, A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577446 · Cited by 10
Growth hormone deficiency in adults with Cushing's disease
Tritos, N. A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101474 · Cited by 11
Markkanen, H. M., Pekkarinen, T., Välimäki, M. J., Alfthan, H. V., Hämäläinen, E. K., & Stenman, U. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.06.002 · Cited by 10
A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening
Tritos, N. A., Byrne, T. N., Wu, C., & Klibanski, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.198 · Cited by 9
Baldelli, R., Bianchi, A., Diacono, F., Passeri, M., Fusco, A., Valle, D. D. L. N. M., Poggi, M., Terlini, M., Toscano, V., Tamburrano, G., et al. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345359 · Cited by 9
Radetti, G., Iorgi, N. D., Paganini, C., Gastaldi, R., Napoli, F., Lorini, R., & Maghnie, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02842.x · Cited by 11
Pena-Bello, L., Seoane‐Pillado, T., Sangiao‐Alvarellos, S., Outeiriño-Blanco, E., Varela-Rodríguez, B. M., Juiz-Valiña, P., Cordido, M., & Cordido, F. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.06.004 · Cited by 11
Holmer, H., Link, K., & Erfurth, E. M. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02436.x · Cited by 11
“In this report (Biller et al., 2002), the patients were much more obese in comparison to the present study, which perhaps may be of importance.”
ResultDefining Growth Hormone Status in Adults with Hypopituitarism
Kaushal, K., & Shalet, S. M. (2007) · Hormone Research in Paediatrics · doi:10.1159/000101286 · Cited by 10
Herman-Bonert, V. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6109-0.00065-4 · Cited by 9
Lanzetta, M. A., Bona, E. D., Tamaro, G., Vidonis, V., Vittori, G., Faleschini, E., Barbi, E., & Tornese, G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1288497 · Cited by 10
Sotos, J. F., Miller, K. E., Corsmeier, D. J., Tokar, N. J., Kelly, B., Nadella, V., Zhong, H., Wetzel, A. N., Adler, B. H., Yu, C. Y., et al. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0052-z · Cited by 10
“The GH level after stimulation tests as an adult was normal indicating normal GH secretion [18, 19].”
BackgroundCentral Adiposity as an Important Confounder in the Diagnosis of Adult Growth Hormone Deficiency
Johannsson, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2020 · Cited by 8
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Gangat, M., & Radovick, S. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.003 · Cited by 8
Neuroendocrine Complications of Cancer Therapy
Leung, W. H., Rose, S. R., & Merchant, T. E. (2005) · Springer eBooks · doi:10.1007/3-540-26498-1_5 · Cited by 8
“Diagnosis of GH deficiency in adults requires evidence of other hypothalamic–pituitary hormone deficiencies and a low peak response to GH stimulation tests [ 1 ].”
BackgroundChang, S. H., & Kim, C. J. (2024) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346234.117 · Cited by 7
Theiler‐Schwetz, V., Trummer, C., Schmitt, L., Terbuch, A., Obermayer-Pietsch, B. M., Richtig, E., & Pilz, S. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2453829 · Cited by 14
Bioletto, F., Parasiliti‐Caprino, M., Berton, A. M., Prencipe, N., Cambria, V., Ghigo, E., Grottoli, S., & Gasco, V. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737947 · Cited by 8
Adult growth hormone deficiency: to treat or not to treat
Tzanela, M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.6.787 · Cited by 8
Growth Hormone Stimulation Tests in Assessing Adult Growth Hormone Deficiency
Yuen, K. C. J. (2016) · Europe PMC (PubMed Central) · Cited by 9
Testing Pituitary Function in Aging Individuals
Giordano, R., Aimaretti, G., Lanfranco, F., Bo, M., Baldi, M., Broglio, F., Baldelli, R., Grottoli, S., Ghigo, E., & Arvat, E. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.004 · Cited by 8
“Levodopa administration often induces nausea and vomiting [25,26,33].”
BackgroundRoberts, B. K., & Katznelson, L. J. (2007) · Pituitary · doi:10.1007/s11102-007-0026-x · Cited by 7
“In a recent study by Biller et al., the GHRH-Arginine test had a similar sensitivity and specificity to ITT at a cut-off of 4.1 ng/ml (95 and 91%, respectively), and was preferred by patients [24].”
BackgroundInfluentialEliciting an antibody response against a recombinant TSH containing fusion protein
Mard‐Soltani, M., Rasaee, M. J., Sheikhi, A., & Hedayati, M. (2016) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2016.1250774 · Cited by 6
“A brief skimming of the contemporary diagnostic processes, particularly diagnosing hyperactivity or hypoactivity of the glands, unveils the necessity of having a protocol which is endowed with expeditious accuracy, sensitivity, and specificity.([8,9]) In this regard, antibody-based methods including enzyme-linked immu…”
MethodMakimura, H., Stanley, T. L., Sun, N., Connelly, J. M., Hemphill, L., & Grinspoon, S. K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03859.x · Cited by 6
Radiation-induced hypopituitarism in children with acute lymphoblastic leukemia
Mirouliaei, M., Shabani, M., Bakhshi, F., & Ordouei, M. (2013) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.113396 · Cited by 7
“[13] However, in one other study, 31-60% of patients with GHD had IGF-I normal rate; therefore, another stimulation test for GHD diagnosis is required.[14] Insulin tolerance test (ITT) is considered as gold standard for diagnosis of GHD in cohort studies at radiotherapy field.”
BackgroundThe macimorelin-stimulated growth hormone test for adult growth hormone deficiency diagnosis
Agrawal, V., & Garcia, J. M. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.915746 · Cited by 6
“However, it is important to know that the cutoff value vary by waist circumference, BMI and age [13].”
BackgroundInfluentialVillafuerte, B., Barrio, R., Martín-Frías, M., Alonso, M., & Roldán, B. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.11.007 · Cited by 6
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety
Tritos, N. A. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101790 · Cited by 6
Growth hormone dosing variables in growth hormone-deficient adults
Cook, D. M., & Yuen, K. C. J. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.03.007 · Cited by 6
Self-citationLanes, R., Boguszewski, C. L., Calzada, R., Cassorla, F. G., Fideleff, H. L., & Boquete, H. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.23.3.225 · Cited by 7
Arginine test is not reliable for diagnosing cerebellar multiple system atrophy
Gardner, R. C., & Schmahmann, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21898 · Cited by 6
“In a study conducted by our hospital of 34 healthy American adults, 59% mounted a peak GH response to arginine of 3 g/l.(14) A virtually identical Italian study of 37 healthy adults, however, reported a mean peak GH response to arginine of 18 g/l (range, 2.”
BackgroundAn overview of the controversies of adult growth hormone deficiency diagnosis
Cuboni, D., Aversa, L. S., Grottoli, S., Ghigo, E., & Gasco, V. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2480699 · Cited by 5
“The GHRH + Arginine test offers an excellent safety profile and minimal contraindications, making it an alternative for patients in whom ITT is unsuitable [25,26].”
Fazeli, P. K., Teoh, J. G., Lam, E. L., Gerweck, A. V., Wexler, T., Teo, E. P., Russell, B. M., Durst, R. Y., McCarty, D., Weiner, R. B., et al. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.12.003 · Cited by 5
“Prior to initiating treatment with GH, all subjects were GH deficient as defined by a peak GH < 5ng/mL in response to GHRH-arginine stimulation, performed as previously described [39], or an IGF-I level more than two standard deviations below the age-specific normal range in subjects who had at least three other anter…”
MethodCattoni, A., Molinari, S., Medici, F., Lorenzo, P. D., Valsecchi, M. G., Masera, N., Adavastro, M., & Biondi, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.599302 · Cited by 5
Wang-Cheng, R. M., & Rosenfeld, J. A. (2002) · BMJ · doi:10.1136/bmjusa.02090003 · Cited by 7
Zayour, D. H., & Azar, S. T. (2006) · Endocrine Practice · doi:10.4158/ep.12.1.59 · Cited by 5
Adult Growth Hormone Deficiency
Gupta, M., Agrawal, N., & Wangnoo, S. (2009) · Apollo Medicine · doi:10.1016/s0976-0016(11)60085-9 · Cited by 5
Partially Reversible Hypopituitarism in an Adolescent with a Rathke Cleft Cyst
Bizzarri, C., Marini, R., Ubertini, G., & Cappa, M. (2012) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.21.75 · Cited by 5
“All these data documented a normal GH secretion for adult age (6).”
BackgroundPituitary function in patients with primary and secondary empty sella
Steckel, L., Gizewski, E. R., & Kaser, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1632824 · Cited by 4
Yuen, K. C. J., Frystyk, J., Rhoads, S. A., & Bidlingmaier, M. (2015) · Pituitary · doi:10.1007/s11102-015-0688-8 · Cited by 4
“Following the publication of several validation studies [6, 7] and recommendations from current consensus guidelines [1–3], the combination Clinical Trials Registry number: NCT01804413.”
MethodSauer, N., Flitsch, J., Doeing, I., Dannheim, V., Burkhardt, T., & Aberle, J. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.03.001 · Cited by 4
Adding Technology to Diagnostic Methods
Radke, B. J. C. (2015) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-4666-6587-3.ch005 · Cited by 4
Portes, E., & Barbosa, E. R. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500018 · Cited by 10
Pituitary dysfunction after traumatic brain injury: screening and hormone replacement
Guttikonda, S., Ahmadi, S., & Urban, R. J. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.59 · Cited by 4
Markkanen, H. M., Pekkarinen, T., Hämäläinen, E. K., Välimäki, M. J., Alfthan, H. V., & Stenman, U. (2017) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2017.07.002 · Cited by 4
“Cut-off values for the GHRH + ARG test may vary based on the controls used [8,9].”
MethodResultVarlamov, E. V., & Fleseriu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00019-6 · Cited by 6
Growth Hormone Stimulation Tests in Pediatrics
Aimaretti, G., Bellone, S., Baldelli, R., Grottoli, S., Bona, G., & Ghigo, E. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000134851.85446.da · Cited by 4
Herman-Bonert, V. S., & Melmed, S. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10004-5 · Cited by 5
Wang, S., Zhou, X., Zhang, Y., Zhang, Q., Huang, B., Wang, Y., Liang, S., Zhou, X., Cheng, X., Pan, H., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.08.006 · Cited by 4
Martínez, J., & Fehrentz, J. (2020) · Australian Journal of Chemistry · doi:10.1071/ch19530 · Cited by 3
Corrales, E. P., Castro, M. A., Ortiz-Flores, A. E., & Escobar-Morreale, H. F. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.004 · Cited by 3
Patterns of hormonal changes in hypophysitis by immune checkpoint inhibitor
Sang, H., Cho, Y. K., Go, S.-H., Kim, H. J., & Koh, E. H. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.523 · Cited by 5
“Growth hormone deficiency was defined as an age-specific serum insulin-like growth factor 1 level lower than the lower limit of normal [24,25].”
BackgroundTraumatic Brain Injury-associated Hypopituitarism-A Case Report with Mini Review
Song, Y.-M. (2020) · 內科學誌 · doi:10.6314/jimt.202010_31(5).09 · Cited by 4
Álvarez‐Escolá, C., Fernández-Rodríguez, E., Recio‐Córdova, J. M., Bernabéu, I., & Fajardo, C. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.08.001 · Cited by 5
Growth Hormone-Releasing Hormone: Clinical Perspectives Revisited
Gelato, M. C. (2005) · The Endocrinologist · doi:10.1097/01.ten.0000162232.25674.d6 · Cited by 3
Siyambalapitiya, S., Ibbotson, V., Doane, A., Ghigo, E., Campbell, M. J., & Ross, R. J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2140 · Cited by 3
“The sequential administration of GHRH with l-arginine (GHRH/arginine test) is a potent stimulus of GH secretion and has become the most commonly used test in the United States (5).”
BackgroundRobles, J. F., Navarro, J. E. V., Domingo-Maglinao, M. L. P., Matawaran, B. J., Silva, A. A. A., & Asis, L. B. M. (2009) · Intern J Endocrinol Metab · Cited by 4
(2014) · PubMed
Kuhn, J., Lefèbvre, H., & Folope, V. (2005) · EMC - Endocrinologie · doi:10.1016/j.emcend.2005.04.001 · Cited by 3
Metadata
- Authors
- Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L.
- Affiliations
- Harvard University (US)
- Oregon Health & Science University (US)
- University Hospitals of Cleveland (US)
- Cedars-Sinai Medical Center (US)
- NYU Langone Health (US)
- Corresponding author
- Biller, Beverly M. K.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-05-01
- Volume
- 87
- Issue
- 5
- Pages
- 2067-2079
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2125896595
- Semantic Scholar
- e5209f92424ddb2dfc412b4606bcb9a11bff13d5
- Cited by
- 423
- References
- 64
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 16 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 25 · 2014: 17 · 2013: 19 · 2012: 17
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- insulin tolerance test, arginine stimulation test, GHRH stimulation test, diagnostic thresholds, sensitivity and specificity, multiple pituitary hormone deficiency, hypothalamic-pituitary disease, insulin-like growth factor I, diagnostic accuracy comparison, pituitary hormone replacement
- MeSH terms
- Adult, Aged, Aging, Arginine, Diagnostic Techniques, Endocrine, Drug Combinations, Female, Humans, Hypoglycemic Agents, Insulin, Insulin-Like Growth Factor I, Levodopa, Male, Metabolic Diseases, Middle Aged, Sensitivity and Specificity, Sex Characteristics, Growth Hormone-Releasing Hormone, Stimulation, Chemical, Body Mass Index, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.